5th International Summit on

Cancer Research and Diagnosis

Paris, France   March 02-03, 2020

GET THE APP

Cancer-2020

Theme: MARCHING TOGETHER TOWARDS A CANCER FREE SOCIETY

5th International Summit on Cancer Research and Diagnosis is delighted to welcome the participants from all over the world to be a part of the summit. Cancer 2020 is scheduled on March 02-03, 2020 in Paris, France. This conference will be organize around the theme Marching Together Towards a Cancer Free Society.
Cancer 2020 will be a platform for plenary speakers, Keynote speakers, Invited speakers and Young Researchers as well as for the youth generation. The summit will work as a discussion point for researchers and experts from all around the world to discuss the cause, effect, prevention as well as the future roadmap of a cancer free society. Paris has tourist attraction places like Eiffel Tower, Louvre Museum, Disneyland and also called as the city of lights. Its multi cultural festivals makes this an obivious place for tourist from all around the globe.

Session on: Cancer Symptoms and Stages

Cancer can trigger almost any sort of symptom, from tiredness, pain, shortness of breath, etc. In some cases, during the early phases of the disease, an individual with cancer will notice symptoms, but in other cases, the cancer may go unnoticed until either the tumor has grown in size or spread to other regions of the body. There are different types of staging systems for different cancers, but the most common is the numbered cancer stage system, which identifies 5 possible stages.

Cancer Conferences|Oncology Meeting|Cancer Therapy Congress|Radiology Congress|Cancer Treatment|DiagnosticsCancer|European Oncology Conference|Cancer Research Conference | Oncology Summit |Cancer Research Congress | Cancer Diagnosis Meet| European Oncology Summit|Cancer 2020

Session on: Cancer Diagnosis and Imaging

In most instances, a diagnosis of cancer requires a biopsy by physicians. A biopsy is an operation where a tissue sample is removed by the doctor. A pathologist then looks under a microscope at the tissue to see whether it's cancer. Imaging is the method by which precious images of buildings and organ are produced. Tumors and other defects are found or detectioned, the magnitude of disease is determined and the efficacy of therapy evaluated. Imaging can also be used for biopsies and other operations.

Cancer Therapy Congress|Oncology Meeting|Cancer Conferences|Radiology Congress|Cancer Treatment|European Oncology Conference|DiagnosticCancer|Cancer Research Conference|European Oncology Summit|Cancer Research Congress|Cancer Diagnosis Meet|Cancer2020

Session on: Radiology and Imaging in Cancer

Radiology is the science used for the analysis and treatment of diseases inside the body with restaurant imagery. A range of imaging solutions is used to analyze or possibly treat diseases, e.g. x-rays, radiographs, ultrasound, recorded tomographics, nuclear pharmaceuticals, including positron discharge tomography (PET) and MRI. Medical imaging aims at revealing inner skin and bone structures and diagnosing and treating disease.Interventional radiology is the execution, with the aim of imaging innovations, of (normally negligible intricate) therapeutic methodology.

Oncology Meeting|Cancer Conferences|DiagnosticsCancer|Cancer Therapy Congress|Radiology Congress|Cancer Treatment|European Oncology Conference|Cancer Diagnosis Conference|European Oncology Summit|Cancer Research Congress |Cancer Diagnosis Meet|Cancer 2020

Session on:Cancer Immunology

Cancer immunology is an interdisciplinary biological industry which deals with the role of the immune systems in the growth and evolution of cancer; cancer immunotherapy is one of the most well-known applications for the treatment of cancer by the immune system. In 1957 Burnet and Thomas created the hypothesis that lymphocytes are sentinels to recognize and continuously remove nascent cells that have been converted. Cancer immunology is a significant host defense technique that decreases cancer rates through carcinogenicity inhibition.

Cancer Conferences|Oncology Meeting|Cancer Therapy Congress|European Oncology Conference|Cancer Treatment|Diagnostics Cancer|Radiology Congress|Cancer Research Conference|Oncology Summit|Cancer Research Congress|Cancer Diagnosis Meet|European Oncology Summit|Cancer 2020

Session on:Cancer Pharmacology

Cancer Pharmacology and discovery for new medication, fundamental mechanisms for DNA repairs and DNA damage tolerance and the creation of novel strategy for gene therapy include the research attempts of Cancer Pharmacology, the research on fundamental signal transmission mechanisms connected with cell proliferation and apoptosis. Cancer Pharmacology the research work on cancer pharmacology includes regulation of tyrosine kinases, proto-oncogenes processing, regulation of GTPases and their effectors, cell-cycle species kinase and DNA gene repair products are considered as prospective objectives or to improve the effectiveness of current chemotherapeutic products.

Cancer Conferences|Oncology Meeting|Cancer Therapy Congress|Radiology Congress|Cancer Treatment|DiagnosticsCancer|European Oncology Conference |Cancer Research Conference|European Oncology Summit|Cancer Research Congress|Cancer Diagnosis Meet|Cancer 2020

Session on:Clinical Trail and Research

Clinical trials are trials that test new drugs efficiency. They are an important component of our quest to find methods of avoiding, treating and curing cancer. The clinical trial has resulted in almost every cancer treatment patient today receiving. Several types of clinical cancer studies are available. Some look at fresh therapies that can assist treat or heal the disease. Other therapies are studied to see if they have fewer side effects than what is presently used to treat the illness. Others can still concentrate on enhancing the quality of life of persons with cancer treatments or cancer.

Cancer Conferences|Oncology Meeting|Cancer Therapy Congress|Radiology Congress|Diagnostics Cancer|Cancer Treatment|European Oncology Cancer|Cancer Diagnosis Conference|Oncology Summit|Cancer Research Congress|Cancer Diagnosis Meet|European Oncology Summit|Cancer 2020

Session on:Targeted Cancer Therapy

Chemotherapy is regarded to be targeted treatment medicines, like other medicines used to treat cancer. Technically, chemotherapy is regarded to be targeted treatment medicines, like other medicines used to treat cancer. For instance, many targeted drugs are used after the inner workings of cancer cells – programs which distinguish them from normal healthy cells and leave the healthiest cells on their own. These medicines tend to have distinct side impacts than conventional chemicals. The primary treatment for certain cancers may be targeted drugs, but in the majority of cases they are used with other therapies such as chemotherapy, surgery and radiation.

Cancer Therapy Congress|Oncology Meeting|Cancer Conferences|Radiology Congress|Cancer Treatment| European Oncology Conference| Diagnostic Cancer|Cancer Research Conference|Oncology Summit|Cancer Research Congress|Cancer Diagnosis Meet|European Oncology Summit|Cancer 2020

Session on:Cancer Prevention and Care

The practice of active action to reduce the incidence of cancer and mortality is prevention of cancer. Prevention depends on the individual attempts to enhance the lifestyle and to pursue preventive screening, as well as socioeconomic or public policy on cancer prevention. Global cancer prevention, because of its application for broad populations, its proactiveness in health practices and behavior and the reduction of long-term impacts of cancer, is seen as a critical goal. We need to follow a balanced life style to avoid this awareness is also necessary keep it away.

Oncology Meeting|Cancer Conferences|DiagnosticsCancer|Cancer Therapy Congress|Radiology Congress|Cancer Treatment|European Oncology Conference|Cancer Research Conference|European Oncology Summit|Cancer Research Congress|Cancer Diagnosis Meet|Cancer 2020

Session on:Cancer Care and Rights

As cancer is a lethal disease, so it needs regular care of the patience with a human touch. It the duty of the society provides them best possible care physically and mentally. The patient needs to be proactive in life so we can minimize the risk of being affected. Likewise we need to understand the financial as well as legal requirements of the cancer patients and those who are dependent on them. Many countries has drafted patient bill of rights who gives them a reference about what they can expect during this critical phase.

Cancer Conferences|Oncology Meeting|Cancer Therapy Congress|European Oncology Conference|Cancer Treatment|Diagnostics Cancer|Radiology Congress|Cancer Diagnosis Conference|European Oncology Summit|Cancer Research Congress|Cancer Diagnosis Meet|Cancer 2020

Session on:Cancer & Society

Patients can find it hard and speak about social and emotional problems. It can also cause other issues, such as depression and anxiety. People affected with cancer and those who leave with them can experience a variety of feelings during their cancer journey. These can include anger, sadness, fear, feeling out of control. These feelings are very common around the time of diagnosis, or when there are changes in the course of cancer treatment. It is evident that patient with cancer has to go through some social and emotional issues during the treatment. So it is our duty to raise awareness about the issue to dream a cancer free society.

Cancer Conferences|Oncology Meeting|Cancer Therapy Congress|Radiology Congress|Cancer Treatment|DiagnosticsCancer|European Oncology Conference|Cancer Diagnosis Conference|Oncology Summit|Cancer Research Congress|Cancer Diagnosis Meet|European Oncology Summit|Cancer 2020

Market Analysis:

Future of Oncology Sector

Over the past decade, there has been a paradigm shift in the management of cancer, driven by developments in personalized medicine and immuno-oncology. In recent years, several new technologies have arisen with the promise of improving the outcomes of cancer treatments by helping the immune system identify and attack tumours, a field known as immuno-oncology. These technologies could make a big difference in the development of effective options that take us closer to being able to cure cancer. Growing research into cancer and its related branches is changing our understanding of diseases and how to tackle this.

Target Audience

  • Cancer research Students, Scientists
  • Cancer Researchers
  • Cancer research Faculty
  • Medical Colleges
  • Cancer Associations and Societies
  • Oncologists
  • Radiologists
  • Chemotherapists
  • Pathologists
  • Physicians
  • Medical Devices Manufacturing Companies
  • Pharmaceutical Companies
  • Diagnostics Companies

Why to attend

  • Stay up to date about the Cancer and its care
  • Gain Practical strategy to fight Cancer
  • Find an innovative solution to root our cancer
  • Be inspired & energized
  • Grow your professional network
Market value in France

As per some research, the worldwide market value of cancer therapies is expected to grow at a compound annual growth rate of 7.4 percent between 2017 and 2022 of the $121 billion in 2016, down to $172.6 billion by 2022. The global cancer therapy market was valued at USD 136,254.35 million in 2018, and is estimated to reach USD 220,701.26 million in 2024.

prominent factors that are driving the oncology related market growth include increasing patient assistance programs(PAPs), increasing, government initiatives for cancer awareness, rising prevalence of cancer worldwide and strong R&D initiatives from key players.

Market value in Europe

In 2017, the worldwide drug market for oncology and cancer was estimated at around 1 lakh million dollars and expected to reach around 1.8 lakh million dollars by 2025. Spending on cancer medicines totalled at $107 billion worldwide in 2015 and is projected to exceed $150 billion by 2020, reflecting adoption of newer, pricier therapies, according to a report from leading healthcare organization.

Global Market Value

As per some leading market research companies, the global market for oncology therapeutic medicines will reach around $200 billion by 2022, averaging 10—13% growth over the next four years from now. Increasing Patient Assistance Programs (PAPs), increasing public initiatives for knowledge of cancer, increasing global incidence of cancer, and powerful R&D initiatives by important actors can contribute to market development. During the prediction period, the target treatment section will demonstrate the largest growth

Top Medical Colleges in France

University of Paris
University of Burgundy
University of Angers
University of Western Brittany
Higher Normal School of Lyon
University of Caen Normandy
University of Strasbourg
Sorbonne University
University of Nantes
University of Limoges
Top Medical Colleges in Europe
Oxford University, UK
University of Valencia, Spain
Cambridge University, UK
The Karolinska Institute, Sweden
Uppsala University, Sweden
Heidelberg University, Germany
The University of Copenhagen, Denmark
Hamburg University, Germany
Erasmus University Rotterdam, Netherlands
Pavia University, Italy
Worldwide Top Medical Colleges
Johns Hopkins University, USA
Stanford University, USA
Imperial College of London, UK
Cambridge University, UK
RWTH Aachen University, Germany
Northern Ontario School of Medicine, Canada
The University of Melbourne, Australia
National University of Singapore, Singapore
The University of Tokyo, Japan
The University of Hong Kong, Hong Kong

Top Pharma companies in world
Lupin Limited
Glenmark Pharmaceuticals
Cipla
Cadila Healthcare
Wockhardt
Roche Holding AG
Bristol-Myers Squibb
Amgen
Sanofi
Pfizer
Conclusion

Globally the costs related with cancer care are higher than the treatment for any other disease, so it leads to the demand for creating a more robust way to find some alternative. Innovative treatments will play a vital role in cancer research and diagnosis sector in the near future. The future paradigm shift requires some fundamental changes and Cancer 2020 will follow that goal to put a small step towards cancer free society.

Meetings International has always been at the forefront to support and encourage the scientific and techno researchers to march forward with their research work. 5th International Summit on Cancer Research and Diagnosis conference offers various awards as reorganization to exceptional researcher and their research work. We invite all enthusiastic researchers from all around the world join us for the 5th International Summit on Cancer Research and Diagnosis scheduled in Paris, France on March 02-03, 2020 date.

Eminent Keynote Speaker Award:

Cancer conference will confer the Model Keynote Speaker Award to the researchers who have spent a considerable time of their academic life towards the research related to conference topic. Keynote speaker award is for the researchers/speakers who have done all the hard work behind the scene. It will be a small clap for their dedication and hard work.

 

Outstanding Speaker Award:

Cancer conference will bestow model speaker award to those researchers who have made significant contribution towards the conference topic during their research period as well as presented the research topic in an impressive way in the oral presentation during the summit. It will be an apt appreciation from the Jury as well as from the delegates.The award they receive will motivate them to march forward with the research work.

Model Organizing Committee Member Award:

Cancer conference will take this opportunity to facilitate eminent experts from this field with the model Organizing Committee Member award for their phenomenal contribution towards the society through their academic research.  This will be a trivial but significant reorganization of their dedication and discipline.

Promising Young Researcher Award:

The motive of this Award during the Cancer conference is to appreciate research work of the budding young researcher who is continuing their research work to create a better society. The award will provide them a tremendous amount of encouragement to keep moving forward.

Educative Poster Award:

The educative poster award for the Cancer conference will be endorsement for those who wishes to display their research paper through a poster and will act as a guiding force those researchers. The award will be presented to the most informative and educative research poster.

Criteria:

  • All presented abstracts will automatically be considered for the Award.
  • All the presentation will be evaluated in the conference venue.
  • All the awards will be selected by the judges of the award category.
  • The winners will be formally announced during the closing ceremony.
  • The winners of the Poster Award will receive award certificate.
  • The awards will be assessed as far as plan and format, intelligence, argumentation and  approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.

Guidelines:

  • All submissions must be in English.
  • The topic must fit into scientific sessions of the conference.
  • Each individual participant is allowed to submit maximum 2 papers.
  • Abstract must be submitted online as per the given abstract template.
  • Abstracts must be written in Times New Roman and font size will be 12.
  • Abstract must contain title, name, affiliation, country, speaker’s biography, recent photograph, image and reference.
  • Each poster should be approximately 1x1 M long. The title, contents and the author’s information should be clearly visible from a distance of 1-2 feet.

Meetings International is announcing Young Scientist Awards through 5th International Summit on Cancer Research and Diagnosis (Cancer 2020) which is scheduled at Paris, France during March 02-03, 2020. This Cancer 2020 focuses on “Cancer Research and Diagnosis”

Cancer 2020 and upcoming conferences will recognise participants to summit will work as a discussion point for researchers and experts from all around the world to discuss the cause, effect, prevention as well as the future roadmap of a cancer free society. The Young Scientist Award will provide a strong professional development opportunity for young researches by meeting experts to exchange and share their experiences at our international conferences.

Cancer 2020 focuses mainly on Cancer Symptoms and Stages Cancer Diagnosis and Imaging, Radiology and Imaging in Cancer, Cancer Immunology, Clinical Trail and Research, Targeted Cancer Therapy, Cancer Prevention and Care. Cancer conference will be a platform for plenary speakers, Keynote speakers, Invited speakers and Young Researchers as well as for the youth generation. The summit will work as a discussion point for researchers and experts from all around the world to discuss the cause, effect, prevention as well as the future roadmap of a cancer free society.

Eligibility:

Plenary speakers, Keynote speakers, Invited speakers and Young Researchers as well as for the youth generation .Persons from Scientific Industry can also participate.

Benefits: The Young Scientist Feature is a platform to promote young researchers in their respective area by giving them a chance to present their achievements and future perspectives.

  • Acknowledgement as YRF Awardee
  • Promotion on the conference website, Young Researcher Awards and certificates
  • Link on the conference website
  • Recognition on Meetings Int. Award Page
  • Chances to coordinate with partners around the world
  • Research work can be published in the relevant journal without any publication fee

Criteria:

  • All presented abstracts will automatically be considered for the Award.
  • All the presentation will be evaluated in the conference venue
  • All the awards will be selected by the judges of the award category
  • The winners of the Young Scientist Award will receive award certificate.
  • The awards will be assessed as far as plan and format, intelligence, argumentation and  approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.

Guidelines:

  • All submissions must be in English.
  • The topic must fit into scientific sessions of the conference
  • Each individual participant is allowed to submit maximum 2 papers
  • Abstract must be submitted online as per the given abstract template
  • Abstracts must be written in Times New Roman and font size will be 12
  • Abstract must contain title, name, affiliation, country, speakers biography, recent photograph, image and reference

Conditions of Acceptance:

To receive the award, the awardee must submit the presentation for which the award is given, for publication at the website, along with author permission. Failure to submit the PPT, and permission within the designated timeframe will result in forfeiture of award.

Award Announcements:

Official announcement of the recipients will occur after the completion of Cancer 2020 Conference.

 

 

 

  • Cancer Symptoms and Stages
  • Cancer Diagnosis and Imaging
  • Radiology and Imaging in Cancer
  • Cancer Immunology
  • Cancer Pharmacology
  • Clinical Trail and Research
  • Targeted Cancer Therapy
  • Cancer Prevention and Care
  • Cancer Care and Rights
  • Cancer & society

3 Organizing Committee Members

Media Partners & Collaborations

  • Cancer 2020

    Media Partner

  • Cancer 2020

    Media Partner

  • Cancer 2020

    Media Partner

  • Cancer 2020

    Media Partner